Trial Profile
A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Liraglutide vs. a Sulphonylurea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2020
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin; Pioglitazone; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TREAT4Ramadan
- 26 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 20 Apr 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
- 24 Dec 2012 Accrual to date is 103% according to United Kingdom Clinical Research Network.